Jean Amiral: Reagent-Dependent Factor X Activity in a Novel Calcium-Sensitive Variant
Jean Amiral, Founder of HYPHEN BioMed, Scientific Consultant at SH-Consulting, shared a post on LinkedIn:
“During ISTH in Paris, this July, we reported an interesting case of a new Calcium-dependent Factor X variant.
Patient’s plasma showed variable Prothrombin Time (PT) measurement and Factor X clotting activity depending on the PT reagent used.
Factor X chromogenic activity and Factor X antigen level were almost normal, although within the lower edge of normal range.
Clinical symptoms remained weak.
Complementary explorations revealed a new Factor X mutation, located at the Gamma-Carboxy-Glutamic domain, and a decreased binding to phospholipids in presence of calcium.
This effect was variable depending on the reagent used.
PT-Phen was the reagent revealing the highest decrease of Factor X coagulant activity (percentage) and low PT value (percentage).
Interestingly, when Calcium (CaCl2) concentration in the reagent was increased in percentage PT and Factor X coagulant activity progressively increased, until they reached a close value to the antigenic level.
This normalization was obtained with a 3-fold higher Calcium concentration than the one currently used.
Plasmas from Healthy population were not affected by the Calcium concentration increase when assayed with assays calibrated in the same working conditions.”
Stay updated with Hemostasis Today.
-
Sep 12, 2026, 14:09Mick Thompson: 2026 AHA/ACC Pulmonary Embolism Guidelines and the Evolving Role of Mechanical Thrombectomy
-
Sep 12, 2026, 14:05Chokri Ben Lamine: Ruxolitinib Safety – Practical Reminders for Hematologists Monitor Blood Counts
-
Sep 12, 2026, 13:53Marta Velia Antonini: Incidence and Outcomes of ECMO Circuit Failure in Children
-
Sep 12, 2026, 13:47Rob Mac Sweeney: How Venoarterial ECMO Can Affect the Gastrointestinal System
-
Sep 12, 2026, 13:46Ishac Nazy: A Newly Uncovered Mechanism Behind a Dangerous Blood-Clotting Disorder
-
Sep 12, 2026, 13:43Latchumanadhas Kalidoss: PETROS vs Infusion Thrombolysis in Mitral Valve Thrombosis
-
Sep 12, 2026, 13:38Claudio Mauro: The Protective Role of Hyodeoxycholic Acid in Liver Cancer
-
Sep 12, 2026, 13:14Jamie Nash: Honoured With the Race and Sanger Award
-
Sep 12, 2026, 13:04James P. Crowley: Blood Thinners After Fracture – Weighing Clot and Bleeding Risks